Analysts on Wall Street project that Hologic (HOLX) will announce quarterly earnings of $0.97 per share in its forthcoming report, representing a decline of 8.5% year over year. Revenues are projected to reach $1 billion, declining 2.5% from the same quarter last year.Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Prior to a company's earnings release, i ...

Hologic (HOLX) ended the recent trading session at $75.36, demonstrating a -0.03% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily gain of 0.87%. Elsewhere, the Dow saw an upswing of 0.67%, while the tech-heavy Nasdaq appreciated by 1.11%.The the stock of medical device maker has risen by 0.16% in the past month, leading the Medical sector's loss of 6.67% and the S&P 500's loss of 3.97%.The investment community will be paying close attention to the earning ...

Hologic, Inc. (HOLX) GYN Surgical is expected to have registered vital contributions from MyoSure and the Related fluid system, with an increasing contribution from its laparoscopic portfolio.Moreover, Hologic’s Molecular Diagnostics business is likely to register strong growth driven by a combination of newer assays like BV and CV/TV.We anticipate HOLX’s second-quarter fiscal 2024 performance, scheduled for release on May 2 after the closing bell, to reflect these aspects.Click here to know how the company ...

Hologic (HOLX) closed the most recent trading day at $77.54, moving +0.27% from the previous trading session. The stock's change was more than the S&P 500's daily loss of 1.2%. At the same time, the Dow lost 0.65%, and the tech-heavy Nasdaq lost 1.79%.The the stock of medical device maker has risen by 1.87% in the past month, leading the Medical sector's loss of 6.57% and the S&P 500's loss of 0.85%.Investors will be eagerly watching for the performance of Hologic in its upcoming earnings disclosure. The co ...

Hologic’s (HOLX) progress in the domestic and international markets, strong pipeline of products and continued solid performance of the Molecular Diagnostics segment bolster our confidence. However, uncertainty related to COVID-19-related test sales and macroeconomic issues persists. The stock carries a Zacks Rank #3 (Hold) currently.Hologic’s Molecular Diagnostics business is registering strong growth, driven by a combination of newer assays like BV, CV/TV and contributions from Amgen and HSV, as well as s ...

In the latest market close, Hologic (HOLX) reached $77.38, with a -0.77% movement compared to the previous day. The stock's change was less than the S&P 500's daily loss of 0.04%. Meanwhile, the Dow experienced a drop of 0.03%, and the technology-dominated Nasdaq saw an increase of 0.03%.Heading into today, shares of the medical device maker had gained 1.21% over the past month, outpacing the Medical sector's loss of 0.6% and lagging the S&P 500's gain of 2.57% in that time.The upcoming earnings release of ...

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Hologic (HOLX) . This company, which is in the Zacks Medical - Instruments industry, shows potential for another earnings beat.When looking at the last two reports, this medical device maker has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 3.93%, on average, in the last two qua ...

Hologic (HOLX) ended the recent trading session at $76.35, demonstrating a +0.58% swing from the preceding day's closing price. This move lagged the S&P 500's daily gain of 0.63%. Elsewhere, the Dow saw an upswing of 0.2%, while the tech-heavy Nasdaq appreciated by 0.82%.The medical device maker's stock has climbed by 2.87% in the past month, exceeding the Medical sector's gain of 0.91% and the S&P 500's gain of 1.76%.The upcoming earnings release of Hologic will be of great interest to investors. On that d ...

Hologic (HOLX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.Shares of this medical device maker have returned +2.1% over the past month versus the Zacks S&P 500 composite's +3.3% change. The Zacks Medical - Instruments industry, to which Hologic belongs, has gained 3.2% over this period. Now the key question is: Where could the stock be headed in the near term?A ...

In the latest market close, Hologic (HOLX) reached $75.64, with a -0.9% movement compared to the previous day. This change lagged the S&P 500's daily gain of 1.12%. Meanwhile, the Dow experienced a rise of 0.61%, and the technology-dominated Nasdaq saw an increase of 1.54%.Prior to today's trading, shares of the medical device maker had gained 3.07% over the past month. This has outpaced the Medical sector's gain of 2.49% and the S&P 500's gain of 2.06% in that time.The investment community will be paying c ...